Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Nanomaterials for cancer immunotherapy, what is the next?. Local targets link to admitted publications; unresolved targets remain external evidence.
Intratumoral rhIL‐12 administration in head and neck squamous cell carcinoma patients induces B cell activation
10.1002/ijc.23756 · 2008 · External reference
Improving cancer immunotherapy through nanotechnology
10.1038/s41568-019-0186-9 · 2019 · External reference
Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy
10.1038/s41565-018-0342-5 · 2019 · External reference
STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity
10.1038/s41563-022-01251-z · 2022 · External reference
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
10.1038/s41565-018-0319-4 · 2019 · External reference
In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy
10.1038/s41551-016-0011 · 2017 · External reference
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
10.1038/nmat2960 · 2011 · External reference
Designer vaccine nanodiscs for personalized cancer immunotherapy
10.1038/nmat4822 · 2017 · External reference
A STING-activating nanovaccine for cancer immunotherapy
10.1038/nnano.2017.52 · 2017 · External reference
A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy
10.1038/s41565-020-00781-4 · 2020 · External reference
Proton-driven transformable nanovaccine for cancer immunotherapy
10.1038/s41565-020-00782-3 · 2020 · External reference
A nanovaccine for antigen self-presentation and immunosuppression reversal as a personalized cancer immunotherapy strategy
10.1038/s41565-022-01098-0 · 2022 · External reference
Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy
10.1038/s41565-022-01245-7 · 2022 · External reference
Targeting the activity of T cells by membrane surface redox regulation for cancer theranostics
10.1038/s41565-022-01261-7 · 2023 · External reference
Nano-optogenetic engineering of CAR T cells for precision immunotherapy with enhanced safety
10.1038/s41565-021-00982-5 · 2021 · External reference
Bioinspired nanotopographical design of drug delivery systems
10.1038/s44222-022-00010-8 · 2023 · External reference
